Report: Valeant's hostile takeover hopes fade as Allergan war continues

Allergan uses the occasion of unrequited buyer Valeant Pharmaceuticals' latest financial report to drive home allegations that the Valeant isn't being upfront about its business and accounting practices.

Valeant Pharmaceuticals, Allergan Inc.

News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/UWhAGL